PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Pharvaris (PHVS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026 [Yahoo! Finance]
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Pharvaris (PHVS) was downgraded by Wall Street Zen from "hold" to "se
Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting [Yahoo! Finance]
Form SCHEDULE 13G/A Pharvaris N.V. Filed by: Bain Capital Life Sciences Fund, L.P.
Form 6-K Pharvaris N.V. For: Jan 12
Form 144 Pharvaris N.V. Filed by: Lu Peng
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.